List of Tables
Table 1. Global Antibacterial Vaccines Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Antibacterial Vaccines Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Antibacterial Vaccines Market Competitive Situation by Manufacturers in 2025
Table 4. Global Antibacterial Vaccines Sales (Units) of Key Manufacturers (2021–2026)
Table 5. Global Antibacterial Vaccines Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Antibacterial Vaccines Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Antibacterial Vaccines Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Antibacterial Vaccines Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Antibacterial Vaccines, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Antibacterial Vaccines, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Antibacterial Vaccines, Product Types and Applications
Table 12. Global Key Manufacturers of Antibacterial Vaccines, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Antibacterial Vaccines Companies by Tier (Tier 1, Tier 2, Tier 3), based on Antibacterial Vaccines Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Antibacterial Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Antibacterial Vaccines Sales by Region (Units), 2021–2026
Table 18. Global Antibacterial Vaccines Sales Market Share by Region (2021–2026)
Table 19. Global Antibacterial Vaccines Sales by Region (Units), 2027–2032
Table 20. Global Antibacterial Vaccines Sales Market Share by Region (2027–2032)
Table 21. Global Antibacterial Vaccines Revenue by Region (US$ Million), 2021–2026
Table 22. Global Antibacterial Vaccines Revenue Market Share by Region (2021–2026)
Table 23. Global Antibacterial Vaccines Revenue by Region (US$ Million), 2027–2032
Table 24. Global Antibacterial Vaccines Revenue Market Share by Region (2027–2032)
Table 25. North America Antibacterial Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Antibacterial Vaccines Sales by Country (Units), 2021–2026
Table 27. North America Antibacterial Vaccines Sales by Country (Units), 2027–2032
Table 28. North America Antibacterial Vaccines Revenue by Country (US$ Million), 2021–2026
Table 29. North America Antibacterial Vaccines Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Antibacterial Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Antibacterial Vaccines Sales by Country (Units), 2021–2026
Table 32. Europe Antibacterial Vaccines Sales by Country (Units), 2027–2032
Table 33. Europe Antibacterial Vaccines Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Antibacterial Vaccines Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Antibacterial Vaccines Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Antibacterial Vaccines Sales by Region (Units), 2021–2026
Table 37. Asia Pacific Antibacterial Vaccines Sales by Region (Units), 2027–2032
Table 38. Asia Pacific Antibacterial Vaccines Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Antibacterial Vaccines Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Antibacterial Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Antibacterial Vaccines Sales by Country (Units), 2021–2026
Table 42. Latin America Antibacterial Vaccines Sales by Country (Units), 2027–2032
Table 43. Latin America Antibacterial Vaccines Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Antibacterial Vaccines Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Antibacterial Vaccines Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Antibacterial Vaccines Sales by Country (Units), 2021–2026
Table 47. Middle East and Africa Antibacterial Vaccines Sales by Country (Units), 2027–2032
Table 48. Middle East and Africa Antibacterial Vaccines Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Antibacterial Vaccines Revenue by Country (US$ Million), 2027–2032
Table 50. Global Antibacterial Vaccines Sales (Units) by Type (2021–2026)
Table 51. Global Antibacterial Vaccines Sales (Units) by Type (2027–2032)
Table 52. Global Antibacterial Vaccines Sales Market Share by Type (2021–2026)
Table 53. Global Antibacterial Vaccines Sales Market Share by Type (2027–2032)
Table 54. Global Antibacterial Vaccines Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Antibacterial Vaccines Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Antibacterial Vaccines Revenue Market Share by Type (2021–2026)
Table 57. Global Antibacterial Vaccines Revenue Market Share by Type (2027–2032)
Table 58. Global Antibacterial Vaccines Price (US$/Unit) by Type (2021–2026)
Table 59. Global Antibacterial Vaccines Price (US$/Unit) by Type (2027–2032)
Table 60. Global Antibacterial Vaccines Sales (Units) by Application (2021–2026)
Table 61. Global Antibacterial Vaccines Sales (Units) by Application (2027–2032)
Table 62. Global Antibacterial Vaccines Sales Market Share by Application (2021–2026)
Table 63. Global Antibacterial Vaccines Sales Market Share by Application (2027–2032)
Table 64. Global Antibacterial Vaccines Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Antibacterial Vaccines Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Antibacterial Vaccines Revenue Market Share by Application (2021–2026)
Table 67. Global Antibacterial Vaccines Revenue Market Share by Application (2027–2032)
Table 68. Global Antibacterial Vaccines Price (US$/Unit) by Application (2021–2026)
Table 69. Global Antibacterial Vaccines Price (US$/Unit) by Application (2027–2032)
Table 70. Emergent BioDefense Operations Lansing Inc. Company Information
Table 71. Emergent BioDefense Operations Lansing Inc. Description and Business Overview
Table 72. Emergent BioDefense Operations Lansing Inc. Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Emergent BioDefense Operations Lansing Inc. Antibacterial Vaccines Product
Table 74. Emergent BioDefense Operations Lansing Inc. Recent Developments/Updates
Table 75. Sanofi Pasteur Company Information
Table 76. Sanofi Pasteur Description and Business Overview
Table 77. Sanofi Pasteur Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Sanofi Pasteur Antibacterial Vaccines Product
Table 79. Sanofi Pasteur Recent Developments/Updates
Table 80. Merck & Co. Company Information
Table 81. Merck & Co. Description and Business Overview
Table 82. Merck & Co. Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Merck & Co. Antibacterial Vaccines Product
Table 84. Merck & Co. Recent Developments/Updates
Table 85. MedImmune LLC Company Information
Table 86. MedImmune LLC Description and Business Overview
Table 87. MedImmune LLC Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. MedImmune LLC Antibacterial Vaccines Product
Table 89. MedImmune LLC Recent Developments/Updates
Table 90. Novartis Vaccines Company Information
Table 91. Novartis Vaccines Description and Business Overview
Table 92. Novartis Vaccines Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Novartis Vaccines Antibacterial Vaccines Product
Table 94. Novartis Vaccines Recent Developments/Updates
Table 95. Diagnostics Ltd. Company Information
Table 96. Diagnostics Ltd. Description and Business Overview
Table 97. Diagnostics Ltd. Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Diagnostics Ltd. Antibacterial Vaccines Product
Table 99. Diagnostics Ltd. Recent Developments/Updates
Table 100. Intercell Biomedical Company Information
Table 101. Intercell Biomedical Description and Business Overview
Table 102. Intercell Biomedical Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Intercell Biomedical Antibacterial Vaccines Product
Table 104. Intercell Biomedical Recent Developments/Updates
Table 105. MassBiologics Company Information
Table 106. MassBiologics Description and Business Overview
Table 107. MassBiologics Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. MassBiologics Antibacterial Vaccines Product
Table 109. MassBiologics Recent Developments/Updates
Table 110. Barr Labs, Inc. Company Information
Table 111. Barr Labs, Inc. Description and Business Overview
Table 112. Barr Labs, Inc. Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Barr Labs, Inc. Antibacterial Vaccines Product
Table 114. Barr Labs, Inc. Recent Developments/Updates
Table 115. Organon Teknika Co. Company Information
Table 116. Organon Teknika Co. Description and Business Overview
Table 117. Organon Teknika Co. Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Organon Teknika Co. Antibacterial Vaccines Product
Table 119. Organon Teknika Co. Recent Developments/Updates
Table 120. GlaxoSmithKline Biologicals Company Information
Table 121. GlaxoSmithKline Biologicals Description and Business Overview
Table 122. GlaxoSmithKline Biologicals Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. GlaxoSmithKline Biologicals Antibacterial Vaccines Product
Table 124. GlaxoSmithKline Biologicals Recent Developments/Updates
Table 125. CSL Ltd. Company Information
Table 126. CSL Ltd. Description and Business Overview
Table 127. CSL Ltd. Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. CSL Ltd. Antibacterial Vaccines Product
Table 129. CSL Ltd. Recent Developments/Updates
Table 130. ID Biomedical Co. Company Information
Table 131. ID Biomedical Co. Description and Business Overview
Table 132. ID Biomedical Co. Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. ID Biomedical Co. Antibacterial Vaccines Product
Table 134. ID Biomedical Co. Recent Developments/Updates
Table 135. Protein Sciences Co. Company Information
Table 136. Protein Sciences Co. Description and Business Overview
Table 137. Protein Sciences Co. Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Protein Sciences Co. Antibacterial Vaccines Product
Table 139. Protein Sciences Co. Recent Developments/Updates
Table 140. Wyeth Pharmaceuticals, Inc. Company Information
Table 141. Wyeth Pharmaceuticals, Inc. Description and Business Overview
Table 142. Wyeth Pharmaceuticals, Inc. Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Wyeth Pharmaceuticals, Inc. Antibacterial Vaccines Product
Table 144. Wyeth Pharmaceuticals, Inc. Recent Developments/Updates
Table 145. Berna Biotech Company Information
Table 146. Berna Biotech Description and Business Overview
Table 147. Berna Biotech Antibacterial Vaccines Sales (Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Berna Biotech Antibacterial Vaccines Product
Table 149. Berna Biotech Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Antibacterial Vaccines Distributors List
Table 153. Antibacterial Vaccines Customers List
Table 154. Antibacterial Vaccines Market Trends
Table 155. Antibacterial Vaccines Market Drivers
Table 156. Antibacterial Vaccines Market Challenges
Table 157. Antibacterial Vaccines Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Antibacterial Vaccines
Figure 2. Global Antibacterial Vaccines Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Antibacterial Vaccines Market Share by Type: 2025 & 2032
Figure 4. Inactivated Vaccines Product Picture
Figure 5. Conjugate Vaccines Product Picture
Figure 6. Live/attenuated Vaccines Product Picture
Figure 7. Global Antibacterial Vaccines Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Antibacterial Vaccines Market Share by Application: 2025 & 2032
Figure 9. Bacterial Diseases
Figure 10. Viral Diseases
Figure 11. Global Antibacterial Vaccines Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Antibacterial Vaccines Market Size (US$ Million), 2021–2032
Figure 13. Global Antibacterial Vaccines Sales (Units), 2021–2032
Figure 14. Global Antibacterial Vaccines Average Price (US$/Unit), 2021–2032
Figure 15. Antibacterial Vaccines Report Years Considered
Figure 16. Antibacterial Vaccines Sales Share by Manufacturers in 2025
Figure 17. Global Antibacterial Vaccines Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Antibacterial Vaccines Players: Market Share by Revenue in Antibacterial Vaccines in 2025
Figure 19. Antibacterial Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Antibacterial Vaccines Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Antibacterial Vaccines Sales Market Share by Country (2021–2032)
Figure 22. North America Antibacterial Vaccines Revenue Market Share by Country (2021–2032)
Figure 23. United States Antibacterial Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Antibacterial Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Antibacterial Vaccines Sales Market Share by Country (2021–2032)
Figure 26. Europe Antibacterial Vaccines Revenue Market Share by Country (2021–2032)
Figure 27. Germany Antibacterial Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Antibacterial Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Antibacterial Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Antibacterial Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Antibacterial Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Antibacterial Vaccines Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Antibacterial Vaccines Revenue Market Share by Region (2021–2032)
Figure 34. China Antibacterial Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Antibacterial Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Antibacterial Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Antibacterial Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Antibacterial Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Antibacterial Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Antibacterial Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Antibacterial Vaccines Sales Market Share by Country (2021–2032)
Figure 42. Latin America Antibacterial Vaccines Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Antibacterial Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Antibacterial Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Antibacterial Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Antibacterial Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Antibacterial Vaccines Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Antibacterial Vaccines Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Antibacterial Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Antibacterial Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Antibacterial Vaccines Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Antibacterial Vaccines by Type (2021–2032)
Figure 53. Global Revenue Market Share of Antibacterial Vaccines by Type (2021–2032)
Figure 54. Global Antibacterial Vaccines Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Antibacterial Vaccines by Application (2021–2032)
Figure 56. Global Revenue Market Share of Antibacterial Vaccines by Application (2021–2032)
Figure 57. Global Antibacterial Vaccines Price (US$/Unit) by Application (2021–2032)
Figure 58. Antibacterial Vaccines Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
